
Alectinib (Alecensa) is a targeted anticancer medicine used to treat adults with ALK-positive non-small cell lung cancer (NSCLC). It belongs to a class of medicines called ALK inhibitors and is prescribed for certain patients after lung cancer surgery or when the cancer has spread to other parts of the body. It helps block the signals responsible for cancer cell growth.
| Generic Name | ALECTINIB |
| Manufacturer | Roche Products India |
| Packing | 56 Capsules |
| Prescribed For | Non-small cell lung cancer. |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Alectinib blocks the activity of an abnormal protein called anaplastic lymphoma kinase (ALK), which can send signals that encourage cancer cells to grow and multiply. By inhibiting this protein, Alectinib helps interrupt cancer-related signalling and control the growth of ALK-positive cancer cells.